1. Radicava represents the first FDA-approved treatment for amyotrophic lateral sclerosis — or Lou Gehrig’s disease — in 22 years.
2. Keytruda may now be used, in combination with chemotherapy, for previously untreated patients with advanced lung cancer.
3. Bavencio may now be used to treat advanced or metastatic bladder cancer in patients whose disease still progresses after chemotherapy.
More articles on supply chain:
WHO calls for global drug price transparency
Patients barter for costly medications on Facebook
PhRMA issues new membership criteria, boots more than 20 drugmakers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
